This inventor holds 1 USPTO granted patent. Top assignee: Exelixis, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Tak Hung
Introduction
Tak Hung is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of biotechnology, particularly in understanding the p53 pathway, which is crucial for regulating cell growth and preventing cancer.
Latest Patents
Tak Hung holds a patent for "HPRP4s modifiers of the p53 pathway and methods of use." This patent identifies human hPRP4 genes as modulators of the p53 pathway, making them potential therapeutic targets for disorders associated with defective p53 function. The patent also provides methods for identifying modulators of p53 by screening for agents that can influence the activity of hPRP4.
Career Highlights
Currently, Tak Hung is associated with Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. His work has contributed to advancing the understanding of cancer biology and potential treatment options.
Collaborations
Some of his notable coworkers include Lori Friedman and Gregory D Plowman, who have collaborated with him on various projects related to cancer research and therapeutic development.
Conclusion
Tak Hung's innovative work in the field of biotechnology, particularly regarding the p53 pathway, highlights his role as a key inventor in advancing cancer treatment. His contributions continue to pave the way for new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile